OBN BioTuesday: Life Sciences Spotlight - AI and Data Innovation in the East of England

OBN BioTuesday: Life Sciences Spotlight - AI and Data Innovation in the East of England

This in-person BioTuesday event will recognise some of the most interesting and progressive AI & Data focused R&D innovators, hailing from the East of England Region.

Companies showcasing at the event are using AI and machine learning to both diagnose and treat the causes of cancer and other diseases, as well as using data anaylsis to optimise the drug discovery process.

The evening will commence with a scene setting update from Dr Namshik Han, Head of Computational Research & Artificial Intelligence, Milner Therapeutics Institute, who will share their insight on the latest innovation in this space, with a particular focus on the East of England Region, followed by 6 x 10-minute company showcase presentations.

All presenters will join for an audience Q&A at the end of the session before a networking drinks reception, which is kindly provided by event host, the Epicentre.

Event Format:

17.30 - 18.00 Delegate Registration

18.00 - 18.10 Welcome and Introductions by OBN and the team at the Epicentre

18.10 - 18.30 Keynote/Industry Update from Dr Namshik Han, Head of Computational Research & Artificial Intelligence, Milner Therapeutics Institute

18.30 - 19.30 Company showcase presentations from:

1) Carlos Luzzani, Co-Founder & CSO of MultiplAI Health

2) Matthew Segall, CEO of Optibrium

3) Davide Pennino, Founder of Biotix

4) Debora Lucarelli, CEO of Enhanc3D Genomics

5) Antony Rix, CEO Co-Founder, Lucida Medical

19.30 - 19.40 Audience Q&A

About our hosts The Epicentre

The fundamental objectives of the Epicentre is to create a space that attracts ambitious, growing technology and life science led SMEs, start-ups and growing businesses to create a vibrant community of innovators and a place in which business can thrive.

  • Delivering flexible work, meeting & event space for start-up/scale-up companies
  • Supporting community development and creating a collaborative 'Community Space' as an attractive destination for business providing opportunities to meet and collaborate with like-minded innovators
  • Expert advice and support to help tenants develop and grow their businesses including additional specialist innovation development support tailored to meet the needs of users

This BioTuesday event is kindly co-marketed with One Nucleus

Terms and Conditions of OBN Events


The Epicentre, Haverhill

England, United Kingdom

If you have any questions please contact Emma Durham

Contact Organizer

+44 7810863370

Show on map


Complimentary Ticket
Standard Price Free


  • Debora Lucarelli (CEO of Enhanc3D Genomics)

    Debora Lucarelli

    CEO of Enhanc3D Genomics


    Enhanc3D Genomics is a spinout company from Babraham Institute (Cambridge, UK). It is founded by academic scientists who are leaders in the fields of regulatory genomics and chromosomal architecture.

    view more
  • Carlos Luzzani (Co-Founder & CSO of MultipIAI Health)

    Carlos Luzzani

    Co-Founder & CSO of MultipIAI Health


    A molecular biologist with 15+ years of experience in Stem Cell biology, a PhD. in cell biology and a MSc. in Biotechnology. The last 5 years I have led a research group that focuses on the underlying mechanisms of soft tissue regeneration, mentored a dozen students and published more than 20 papers. Born and raised in academia, I recently started to make my way into the startup world. Especially interested in how to better bring innovation from the bench to the bedside, I co-founded MultiplAI Health to make preventative screening of cardiovascular diseases available to everyone in the world.

    view more
  • Davide Pennino (Founder of Biotix LTD)

    Davide Pennino

    Founder of Biotix LTD

    view more
  • Antony Rix (CEO and Co Founder of Lucida Medical)

    Antony Rix

    CEO and Co Founder of Lucida Medical

    Antony started his career developing machine learning-based software using models of the human auditory system to measure phone call quality, winning an international standards competition, gaining his PhD and co-founding his first startup based on the technology. Psytechnics was acquired by Netscout in 2011. After 12 years developing communications systems and medical devices at Cambridge-based technology consultancy TTP, he returned to startups in 2016. Antony has focused on applying his expertise in AI and medical technology to cancer screening since 2018, and in 2019 co-founded Lucida Medical with Prof Evis Sala, Professor of Oncological Imaging at the University of Cambridge.

    view more
  • Matthew Segall (CEO of Optibrium)

    Matthew Segall

    CEO of Optibrium


    Matthew Segall is CEO of Optibrium. He has an MSc in Computation from the University of Oxford and a PhD in theoretical physics from the University of Cambridge. Since 2001, Matthew has led teams developing predictive models and intuitive decision-support and visualization tools for drug discovery. In 2009 he led a management buyout of the StarDrop™ business to found Optibrium, which develops novel technologies and ground-breaking artificial intelligence software, including Cerella™ and Inspyra™, that improve the efficiency and productivity of drug discovery.

    view more